0001104659-24-098692.txt : 20240910 0001104659-24-098692.hdr.sgml : 20240910 20240910194355 ACCESSION NUMBER: 0001104659-24-098692 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240906 FILED AS OF DATE: 20240910 DATE AS OF CHANGE: 20240910 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Fain Eric S CENTRAL INDEX KEY: 0001402222 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39421 FILM NUMBER: 241291218 MAIL ADDRESS: STREET 1: ONE ST JUDE MEDICAL DRIVE CITY: ST. PAUL STATE: MN ZIP: MN ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Orchestra BioMed Holdings, Inc. CENTRAL INDEX KEY: 0001814114 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 150 UNION SQUARE DRIVE CITY: NEW HOPE STATE: PA ZIP: 18938 BUSINESS PHONE: 646-343-9298 MAIL ADDRESS: STREET 1: 150 UNION SQUARE DRIVE CITY: NEW HOPE STATE: PA ZIP: 18938 FORMER COMPANY: FORMER CONFORMED NAME: Health Sciences Acquisitions Corp 2 DATE OF NAME CHANGE: 20200603 4 1 tm2423769-1_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-09-06 0 0001814114 Orchestra BioMed Holdings, Inc. OBIO 0001402222 Fain Eric S C/O ORCHESTRA BIOMED HOLDINGS, INC. 150 UNION SQUARE DRIVE NEW HOPE PA 18938 1 0 0 0 0 Common Stock, par value $0.0001 per share ("Common Stock") 2024-09-06 4 S 0 2000 5.64 D 44810 I By the Fain Living Trust Common Stock 2024-09-09 4 S 0 1800 5.43 D 43010 I By the Fain Living Trust Common Stock 2024-09-10 4 S 0 1800 5.34 D 41210 I By the Fain Living Trust The shares reported as disposed herein were granted on July 20, 2023 as restricted stock units ("RSUs"). The disposition of shares is associated with tax obligations of the reporting person associated with the vesting of the RSUs. The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.54 to $5.78, inclusive. The reporting person hereby undertakes to provide upon request to the staff of the Securities and Exchange Commission (the "SEC"), the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.38 to $5.53, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote. The price reported reflects the weighted average sales price. These shares were sold in multiple transactions at prices ranging from $5.14 to $5.69, inclusive. The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or any security holder of the Issuer full information regarding the number of shares sold at each separate price within the range set forth in this footnote. /s/ Andrew Taylor, Attorney-in-Fact 2024-09-10